ADC Therapeutics SA Common Stock Shares Outstanding

Quick Answer

ADC Therapeutics SA reported Common Stock Shares Outstanding of 125.75 million shares for the year ending 2025.

  • ADC Therapeutics SA showed an increase of +27.2% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from ADC Therapeutics SA's annual report (Form 10-K), filed with the SEC on March 10, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), ADC Therapeutics SA's Common Stock Shares Outstanding has grown by 55.9%.
  • Historical annual values: Fiscal year 2025: 125.75 million shares | Fiscal year 2024: 98.86 million shares | Fiscal year 2023: 82.29 million shares | Fiscal year 2022: 80.64 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: